- Research works
- 105 ▲ 287% vs 2013–17
- Citations
- 370 3.5 per fractional work
- Top-10% rate
- 5.3% record average 16.5%
- Open access
- 64% world 28%
Not ranked overall: BIOCAD (Russia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 9.9×. Every wedge is a field page.
- Veterinary 9.9×
- Immunology and Microbiology 8.5×
- Mathematics 2.7×
- Chemical Engineering 2.6×
- Biochemistry, Genetics and Molecular Biology 2.4×
- Medicine 2.2×
- Neuroscience 1.7×
- Decision Sciences 1.6×
- Chemistry 1.3×
- Economics, Econometrics and Finance 1.1×
- Agricultural and Biological Sciences 0.8×
- Computer Science 0.7×
- Engineering 0.5×
- Nursing 0.5×
- Business, Management and Accounting 0.4×
- Materials Science 0.4×
- Health Professions 0.2×
- Environmental Science 0.1×
- Pharmacology, Toxicology and Pharmaceutics 0.1×
- Social Sciences 0.1×
Who are the top researchers at BIOCAD (Russia)?
Ranked on the composite score, Roman Ivanov lead among researchers whose main affiliation is BIOCAD (Russia).
- 1 Roman Ivanov Russia · #717,198 worldwide 20 citations · 21 works
Which keywords describe research at BIOCAD (Russia)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Autoantibodies, Cancer Immunotherapy, Biopharmaceuticals and Immunogenicity.
- Spinal Muscular Atrophy
- Health Research
- CAR T Cells
- Tumor Regression
- Machine Learning
- Immune System
- Biosimilars
- Rheumatoid Arthritis
- Ethical Considerations
- Chemotherapy
- Cytokines
- Educational Technology
- Clinical Outcomes
- Cancer Immunotherapy
- Inflammation
- Fc Receptors
- Cancer
- Epidemiology
- Monoclonal Antibodies
- Therapeutic Antibodies
- Antibody Engineering
- Immunotherapy
- Autoantibodies
- Biopharmaceuticals
- E-Learning
- Immunogenicity
- Biological Therapy
- Deep Learning
- Public Health
- Bioanalytical Methods
- Cancer Progression
- Lymphoma
- Pathogenesis
- Biomedical Science
- Chimeric Antigen Receptor
- SMN1
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 36 words, with their numbers
- Monoclonal Antibodies3▲ 100×3 topics
- Epidemiology2▲ 1.62×10 topics
- Therapeutic Antibodies2▲ 85×2 topics
- Cancer2▲ 3.9×8 topics
- Antibody Engineering2▲ 87×1 topic
- Fc Receptors2▲ 87×1 topic
- Immunotherapy2▲ 6.3×6 topics
- Inflammation2▲ 2.3×4 topics
- Autoantibodies2▲ 19×4 topics
- Cancer Immunotherapy2▲ 28×3 topics
- Biopharmaceuticals2▲ 81×2 topics
- Clinical Outcomes2▲ 19×2 topics
- E-Learning2▲ 4.0×3 topics
- Educational Technology2▲ 3.4×3 topics
- Immunogenicity2▲ 97×2 topics
- Cytokines1▲ 12×2 topics
- Biological Therapy1▲ 60×1 topic
- Chemotherapy1▲ 4.5×9 topics
- Deep Learning1◆ 0.94×4 topics
- Ethical Considerations1▲ 9.3×2 topics
- Public Health1▲ 2.2×2 topics
- Rheumatoid Arthritis1▲ 35×1 topic
- Bioanalytical Methods1▲ 149×1 topic
- Biosimilars1▲ 149×1 topic
- Cancer Progression1▲ 16×3 topics
- Immune System1▲ 12×3 topics
- Lymphoma1▲ 18×2 topics
- Machine Learning1◆ 0.94×5 topics
- Pathogenesis1▲ 5.9×4 topics
- Tumor Regression1▲ 27×2 topics
- Biomedical Science1▲ 140×1 topic
- CAR T Cells1▲ 38×1 topic
- Chimeric Antigen Receptor1▲ 38×1 topic
- Health Research1▲ 26×1 topic
- SMN11▲ 128×1 topic
- Spinal Muscular Atrophy1▲ 128×1 topic
Which research topics does BIOCAD (Russia) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Rheumatoid Arthritis Research and Therapies, Biosimilars and Bioanalytical Methods and Neurogenetic and Muscular Disorders Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 2 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
- 3 Biosimilars and Bioanalytical Methods Immunology 1 works
- 4 Neurogenetic and Muscular Disorders Research Genetics 1 works
- 5 CAR-T cell therapy research Oncology 1 works
- 6 Science, Research, and Medicine Reproductive Medicine 1 works
- 7 Spondyloarthritis Studies and Treatments Rheumatology 1 works
- 8 Educational Innovations and Challenges Information Systems 1 works
- 9 RNA modifications and cancer Molecular Biology 1 works
- 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has BIOCAD (Russia)'s research output changed?
Output in 2018–2022 was 287% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.